Antepartum vitamin K and phenobarbital for preventing intraventricular hemorrhage in the premature newborn: A randomized, double-blind, placebo-controlled trial

J. A. Thorp, J. Parriott, D. Ferrette-Smith, B. A. Meyer, G. R. Cohen, J. Johnson

Research output: Contribution to journalArticle

22 Citations (Scopus)

Abstract

Objective: To determine whether antepartum phenobarbital and vitamin K reduce the risk of intraventricular hemorrhage in premature newborns. Methods: Patients at imminent risk for spontaneous or indicated premature delivery between 24-34 weeks' gestation were randomized to receive either placebo or vitamin K and phenobarbital. All patients received betamethasone and antibiotics and were managed uniformly by a single perinatal group in one hospital. All newborns were managed uniformly in the same facility by a single neonatal group. Results: There was a nonsignificant reduction in all grades of intraventricular hemorrhage in the treatment group when compared to the placebo group (48.2 versus 38.3%; P > .05). Frequencies were reduced for severe intraventricular hemorrhage (grades 3 and 4) (6.0 versus 2.5%; P > .05) and mild intraventricular hemorrhage (grades 1 and 2) (42.2 versus 35.8%; P > .05). Conclusions: Antepartum phenobarbital and vitamin K effected a nonsignificant reduction in both mild and severe intraventricular hemorrhage. The incidence of severe intraventricular hemorrhage in our control group was significantly less than that observed in previous studies.

Original languageEnglish (US)
Pages (from-to)70-76
Number of pages7
JournalObstetrics and Gynecology
Volume83
Issue number1
StatePublished - 1994

Fingerprint

Vitamin K
Phenobarbital
Placebos
Newborn Infant
Hemorrhage
Betamethasone
Anti-Bacterial Agents
Pregnancy
Control Groups
Incidence

ASJC Scopus subject areas

  • Obstetrics and Gynecology

Cite this

Antepartum vitamin K and phenobarbital for preventing intraventricular hemorrhage in the premature newborn : A randomized, double-blind, placebo-controlled trial. / Thorp, J. A.; Parriott, J.; Ferrette-Smith, D.; Meyer, B. A.; Cohen, G. R.; Johnson, J.

In: Obstetrics and Gynecology, Vol. 83, No. 1, 1994, p. 70-76.

Research output: Contribution to journalArticle

@article{616edd48ed6a439395fbefdf6bff2b96,
title = "Antepartum vitamin K and phenobarbital for preventing intraventricular hemorrhage in the premature newborn: A randomized, double-blind, placebo-controlled trial",
abstract = "Objective: To determine whether antepartum phenobarbital and vitamin K reduce the risk of intraventricular hemorrhage in premature newborns. Methods: Patients at imminent risk for spontaneous or indicated premature delivery between 24-34 weeks' gestation were randomized to receive either placebo or vitamin K and phenobarbital. All patients received betamethasone and antibiotics and were managed uniformly by a single perinatal group in one hospital. All newborns were managed uniformly in the same facility by a single neonatal group. Results: There was a nonsignificant reduction in all grades of intraventricular hemorrhage in the treatment group when compared to the placebo group (48.2 versus 38.3{\%}; P > .05). Frequencies were reduced for severe intraventricular hemorrhage (grades 3 and 4) (6.0 versus 2.5{\%}; P > .05) and mild intraventricular hemorrhage (grades 1 and 2) (42.2 versus 35.8{\%}; P > .05). Conclusions: Antepartum phenobarbital and vitamin K effected a nonsignificant reduction in both mild and severe intraventricular hemorrhage. The incidence of severe intraventricular hemorrhage in our control group was significantly less than that observed in previous studies.",
author = "Thorp, {J. A.} and J. Parriott and D. Ferrette-Smith and Meyer, {B. A.} and Cohen, {G. R.} and J. Johnson",
year = "1994",
language = "English (US)",
volume = "83",
pages = "70--76",
journal = "Obstetrics and Gynecology",
issn = "0029-7844",
publisher = "Lippincott Williams and Wilkins",
number = "1",

}

TY - JOUR

T1 - Antepartum vitamin K and phenobarbital for preventing intraventricular hemorrhage in the premature newborn

T2 - A randomized, double-blind, placebo-controlled trial

AU - Thorp, J. A.

AU - Parriott, J.

AU - Ferrette-Smith, D.

AU - Meyer, B. A.

AU - Cohen, G. R.

AU - Johnson, J.

PY - 1994

Y1 - 1994

N2 - Objective: To determine whether antepartum phenobarbital and vitamin K reduce the risk of intraventricular hemorrhage in premature newborns. Methods: Patients at imminent risk for spontaneous or indicated premature delivery between 24-34 weeks' gestation were randomized to receive either placebo or vitamin K and phenobarbital. All patients received betamethasone and antibiotics and were managed uniformly by a single perinatal group in one hospital. All newborns were managed uniformly in the same facility by a single neonatal group. Results: There was a nonsignificant reduction in all grades of intraventricular hemorrhage in the treatment group when compared to the placebo group (48.2 versus 38.3%; P > .05). Frequencies were reduced for severe intraventricular hemorrhage (grades 3 and 4) (6.0 versus 2.5%; P > .05) and mild intraventricular hemorrhage (grades 1 and 2) (42.2 versus 35.8%; P > .05). Conclusions: Antepartum phenobarbital and vitamin K effected a nonsignificant reduction in both mild and severe intraventricular hemorrhage. The incidence of severe intraventricular hemorrhage in our control group was significantly less than that observed in previous studies.

AB - Objective: To determine whether antepartum phenobarbital and vitamin K reduce the risk of intraventricular hemorrhage in premature newborns. Methods: Patients at imminent risk for spontaneous or indicated premature delivery between 24-34 weeks' gestation were randomized to receive either placebo or vitamin K and phenobarbital. All patients received betamethasone and antibiotics and were managed uniformly by a single perinatal group in one hospital. All newborns were managed uniformly in the same facility by a single neonatal group. Results: There was a nonsignificant reduction in all grades of intraventricular hemorrhage in the treatment group when compared to the placebo group (48.2 versus 38.3%; P > .05). Frequencies were reduced for severe intraventricular hemorrhage (grades 3 and 4) (6.0 versus 2.5%; P > .05) and mild intraventricular hemorrhage (grades 1 and 2) (42.2 versus 35.8%; P > .05). Conclusions: Antepartum phenobarbital and vitamin K effected a nonsignificant reduction in both mild and severe intraventricular hemorrhage. The incidence of severe intraventricular hemorrhage in our control group was significantly less than that observed in previous studies.

UR - http://www.scopus.com/inward/record.url?scp=0028053031&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0028053031&partnerID=8YFLogxK

M3 - Article

C2 - 8272312

AN - SCOPUS:0028053031

VL - 83

SP - 70

EP - 76

JO - Obstetrics and Gynecology

JF - Obstetrics and Gynecology

SN - 0029-7844

IS - 1

ER -